Document is current
Any future updates will be listed below
-
Authors
Valachis, Antonis
Lindman, Henrik
- License Information
-
More Information
Article History
Received: 22 September 2023
Accepted: 3 August 2024
First Online: 13 August 2024
Competing interests
: The authors declare the following competing financial or non-financial interests related to the study: AV has received institutional fees for participating in expert advisory board and consensus meeting organized by Novartis and as invited speaker. HL has received institutional fees for participating in expert advisory board and consensus meeting organized by Novartis. For Novartis-sponsored TELEPIK study, both authors served as Primary Investigators in their Institutions without receiving any compensation.
